FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2193233774> ?p ?o ?g. }

• W2193233774 endingPage "e180" @default.
• W2193233774 startingPage "e180" @default.
• W2193233774 abstract "Abstract Background/Objective: Plasma apoB predicts the incidence of type 2 diabetes (T2D); however, the link between apoB-linpoproteins and risks for T2D remain unclear. Insulin resistance (IR) and compensatory hyperinsulinemia characterize prediabetes, and the involvement of an activated interleukin-1 (IL-1) family, mainly IL-1β and its receptor antagonist (IL-Ra), is well documented. ApoB-lipoproteins were reported to promote IL-1β secretion in immune cells; however, in vivo evidence is lacking. We hypothesized that obese subjects with hyperapoB have an activated IL-1 system that explains hyperinsulinemia and IR in these subjects. Subjects/Methods: We examined 81 well-characterized normoglycemic men and postmenopausal women (⩾27 kg m −2 , 45–74 years, non-smokers, sedentary, free of chronic disease). Insulin secretion and sensitivity were measured by the gold-standard Botnia clamp, which is a combination of a 1-h intravenous glucose tolerance test (IVGTT) followed by 3-h hyperinsulinemic euglycemic clamp. Results: Plasma IL-1β was near detection limit (0.071–0.216 pg ml −1 ), while IL-1Ra accumulated at 1000-folds higher (77–1068 pg ml −1 ). Plasma apoB (0.34–1.80 g l −1 ) associated significantly with hypersinsulinemia (total IVGTT : C-peptide r =0.27, insulin r =0.22), IR (M/I=−0.29) and plasma IL-1Ra ( r =0.26) but not with IL-1β. Plasma IL-1Ra associated with plasma IL-1β ( r =0.40), and more strongly with hyperinsulinemia and IR than apoB, while the association of plasma IL-1β was limited to second phase and total insulin secretion ( r =0.23). Adjusting the association of plasma apoB to hyperinsulinemia and IR for IL-1Ra eliminated these associations. Furthermore, despite equivalent body composition, subjects with hyperapoB (⩾80th percentile, 1.14 g l −1 ) had higher C-peptide secretion and lower insulin sensitivity than those with low plasma apoB (⩽20th percentile, 0.78 g l −1 ). Adjustment for plasma IL-1 Ra eliminated all group differences. Conclusion: Plasma apoB is associated with hyperinsulinemia and IR in normoglycemic obese subjects, which is eliminated upon adjustment for plasma IL-1Ra. This may implicate the IL-1 family in elevated risks for T2D in obese subjects with hyperapoB." @default.
• W2193233774 created "2016-06-24" @default.
• W2193233774 creator A5042940022 @default.
• W2193233774 creator A5063991367 @default.
• W2193233774 creator A5072109662 @default.
• W2193233774 creator A5081653871 @default.
• W2193233774 creator A5082725138 @default.
• W2193233774 creator A5084416174 @default.
• W2193233774 date "2015-09-28" @default.
• W2193233774 modified "2023-10-03" @default.
• W2193233774 title "Plasma IL-1Ra: linking hyperapoB to risk factors for type 2 diabetes independent of obesity in humans" @default.
• W2193233774 cites W1508663745 @default.
• W2193233774 cites W151562272 @default.
• W2193233774 cites W1542603599 @default.
• W2193233774 cites W1598254642 @default.
• W2193233774 cites W1966977991 @default.
• W2193233774 cites W1973430093 @default.
• W2193233774 cites W1990716354 @default.
• W2193233774 cites W1992012350 @default.
• W2193233774 cites W1997970555 @default.
• W2193233774 cites W2002807148 @default.
• W2193233774 cites W2011267160 @default.
• W2193233774 cites W2015072700 @default.
• W2193233774 cites W2018818691 @default.
• W2193233774 cites W2018876173 @default.
• W2193233774 cites W2019508880 @default.
• W2193233774 cites W2022758651 @default.
• W2193233774 cites W2023300718 @default.
• W2193233774 cites W2030190783 @default.
• W2193233774 cites W2037012409 @default.
• W2193233774 cites W2042572766 @default.
• W2193233774 cites W2043784314 @default.
• W2193233774 cites W2049583719 @default.
• W2193233774 cites W2050076638 @default.
• W2193233774 cites W2052460642 @default.
• W2193233774 cites W2052683476 @default.
• W2193233774 cites W2053264250 @default.
• W2193233774 cites W2053963810 @default.
• W2193233774 cites W2054489926 @default.
• W2193233774 cites W2054755114 @default.
• W2193233774 cites W2062078854 @default.
• W2193233774 cites W2069440471 @default.
• W2193233774 cites W2072384117 @default.
• W2193233774 cites W2074685860 @default.
• W2193233774 cites W2076458350 @default.
• W2193233774 cites W2077149049 @default.
• W2193233774 cites W2089239409 @default.
• W2193233774 cites W2090789566 @default.
• W2193233774 cites W2090918098 @default.
• W2193233774 cites W2100599316 @default.
• W2193233774 cites W2108125385 @default.
• W2193233774 cites W2110206332 @default.
• W2193233774 cites W2111421981 @default.
• W2193233774 cites W2114002503 @default.
• W2193233774 cites W2114041992 @default.
• W2193233774 cites W2118744821 @default.
• W2193233774 cites W2124335748 @default.
• W2193233774 cites W2124848390 @default.
• W2193233774 cites W2127512458 @default.
• W2193233774 cites W2133222023 @default.
• W2193233774 cites W2133717826 @default.
• W2193233774 cites W2140165859 @default.
• W2193233774 cites W2140341996 @default.
• W2193233774 cites W2141630823 @default.
• W2193233774 cites W2143344616 @default.
• W2193233774 cites W2153188717 @default.
• W2193233774 cites W2153252269 @default.
• W2193233774 cites W2156828676 @default.
• W2193233774 cites W2157982405 @default.
• W2193233774 cites W2158603123 @default.
• W2193233774 cites W2162116935 @default.
• W2193233774 cites W2167915346 @default.
• W2193233774 cites W2183454150 @default.
• W2193233774 doi "https://doi.org/10.1038/nutd.2015.30" @default.
• W2193233774 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4657760" @default.
• W2193233774 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26417659" @default.
• W2193233774 hasPublicationYear "2015" @default.
• W2193233774 type Work @default.
• W2193233774 sameAs 2193233774 @default.
• W2193233774 citedByCount "20" @default.
• W2193233774 countsByYear W21932337742016 @default.
• W2193233774 countsByYear W21932337742017 @default.
• W2193233774 countsByYear W21932337742018 @default.
• W2193233774 countsByYear W21932337742019 @default.
• W2193233774 countsByYear W21932337742020 @default.
• W2193233774 countsByYear W21932337742021 @default.
• W2193233774 countsByYear W21932337742022 @default.
• W2193233774 countsByYear W21932337742023 @default.
• W2193233774 crossrefType "journal-article" @default.
• W2193233774 hasAuthorship W2193233774A5042940022 @default.
• W2193233774 hasAuthorship W2193233774A5063991367 @default.
• W2193233774 hasAuthorship W2193233774A5072109662 @default.
• W2193233774 hasAuthorship W2193233774A5081653871 @default.
• W2193233774 hasAuthorship W2193233774A5082725138 @default.
• W2193233774 hasAuthorship W2193233774A5084416174 @default.
• W2193233774 hasBestOaLocation W21932337741 @default.
• W2193233774 hasConcept C126322002 @default.
• W2193233774 hasConcept C134018914 @default.

• next